Skip to main content
. Author manuscript; available in PMC: 2010 Jul 8.
Published in final edited form as: Invest New Drugs. 2009 Jan 8;27(5):461–468. doi: 10.1007/s10637-008-9210-8

TABLE 4.

Type of cancer, prior chemotherapy and best response to current chemotherapy

Disease Site Prior fluoropyrimidine? Number of prior chemotherapy regimens Best response
Dose Level 1
Colorectal yes 2 PD
Colorectal yes 4 SD
Esophageal yes 1 SD
Dose Level 2
Cholangiocarcinoma yes 3 N/A
Colorectal yes 1 PD
Colorectal yes 3 N/A
Unknown no 0 SD
Pancreas no 1 SD
Gastric no 0 PR
Esophageal no 1 PR
Pancreatic no 1 PD
Cholangiocarcinoma no 0 PD
Cholangiocarcinoma no 0 SD
Colorectal yes 1 SD
Esophageal no 1 PD
Dose Level 3
Pancreas no 1 N/A
Gallbladder no 0 SD
Colorectal no 0 PD
Ovarian no 4 SD
Pancreas yes 1 N/A
Pancreas no 1 PD
Dose Level 4
Pancreas no 0 SD
Colorectal yes 1 SD
Ovarian no 3 PD
Bladder no 5 PD
Cholangiocarcinoma yes 1 SD
Esophageal no 2 SD
Unknown yes 2 SD
Cholangiocarcinoma no 2 PD
Gastric yes 1 SD
Breast yes 6 PD
Cholangiocarcinoma no 1 PD
Dose Level 5
Pancreas no 1 N/A
Cholangiocarcinoma no 2 PR
Gastric yes 2 CR
Cholangiocarcinoma no 0 N/A

Bolded text indicates DLT